Nanobiotix

ASCO24 preview: A look at some of the cancer meeting’s hottest abstracts
BioSpace
Fri, 05/31/24 - 11:03 am
ASCO 2024
Merus
JNJ
CAR-T
Legend Biotech
Pfizer
Genmab
Nanobiotix
Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
Medical Marketing and Media
Tue, 07/11/23 - 11:27 pm
JNJ
Janssen
Nanobiotix
NBTXR3
soft tissue sarcoma
Hensify
J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal
BioSpace
Mon, 07/10/23 - 09:36 pm
JNJ
Nanobiotix
NBTXR3
radiotherapy
head and neck cancer
Another biotech that went public in pandemic boom aims to weather the bear market through R&D cutbacks
Endpoints
Thu, 05/19/22 - 10:54 am
Nanobiotix
R&D
Nanobiotix gets FDA fast track status for NBTXR3 to investigate in head and neck cancer
Pharmaceutical Business Review
Tue, 02/11/20 - 10:29 am
Nanobiotix
FDA
NBTXR3
cetuximab
squamous cell carcinoma of the head and neck
Nanobiotix Achieves Primary and Secondary Endpoints in Ph II/III Study in Soft Tissue Sarcoma with NBTXR3
CP Wire
Fri, 06/22/18 - 10:14 am
Nanobiotix
NBTXR3
soft tissue sarcoma
NANOBIOTIX Achieves Primary and Secondary Endpoints in Ph II/III Study in Soft Tissue Sarcoma with NBTXR3
Fri, 06/22/18 - 10:09 am
Nanobiotix
FDA green light sets Nanobiotix up to start nanoparticle prostate cancer trial
Fierce Biotech
Thu, 01/7/16 - 08:54 am
Nanobiotix
prostate cancer
FDA
NBTXR3
nanoparticle therapy